TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
6.1. Overview
6.2. Oncology
6.3. Central Nervous System
6.4. Cardiovascular
6.5. Respiratory
6.6. Metabolic Disorders
6.7. Gastrointestinal
6.8. Other Therapeutic Areas
7. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE
7.1. Overview
7.2. Target ID/Validation
7.3. Hit Generation and Selection
7.4. Lead Identification
7.5. Lead Optimization
8. GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Small Molecule Drug Discovery Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Small Molecule Drug Discovery Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. Pfizer Inc.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Merck & Co., Inc.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Novartis AG
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Johnson & Johnson
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. AstraZeneca PLC
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. GlaxoSmithKline plc
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Bristol Myers Squibb Company
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Eli Lilly and Company
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. ROCHE HOLDING AG
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. AbbVie Inc.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 7 US: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 8 US: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 9 CANADA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 10 CANADA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 7 ITALY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 8 ITALY: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 11 UK: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 12 UK: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 19 JAPAN: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 20 CHINA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 21 INDIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 22 INDIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, BY PROCESS/PHASE, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET
FIGURE 4 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY THERAPEUTIC AREA, 2023
FIGURE 5 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY PROCESS/PHASE, 2023
FIGURE 6 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: SMALL MOLECULE DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL SMALL MOLECULE DRUG DISCOVERY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 PFIZER INC.: SWOT ANALYSIS
FIGURE 14 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 MERCK & CO., INC.: SWOT ANALYSIS
FIGURE 16 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 NOVARTIS AG: SWOT ANALYSIS
FIGURE 18 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 JOHNSON & JOHNSON: SWOT ANALYSIS
FIGURE 20 ASTRAZENECA PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 ASTRAZENECA PLC: SWOT ANALYSIS
FIGURE 22 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 24 BRISTOL MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BRISTOL MYERS SQUIBB COMPANY: SWOT ANALYSIS
FIGURE 26 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 28 ROCHE HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ROCHE HOLDING AG: SWOT ANALYSIS
FIGURE 30 ABBVIE INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ABBVIE INC.: SWOT ANALYSIS
